Globotriaosylceramide inhibits iNKT-cell activation in a CD1d-dependent manner

The Identification of the Endogenous Ligands of Natural Killer T Cells Reveals the Presence of Mammalian α-Linked Glycosylceramides

(2014) Lisa Kain et al.   IMMUNITY

Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease

(2013) Catia S. Pereira et al.   MOLECULAR GENETICS AND METABOLISM

Sulfatide inhibits  -galactosylceramide presentation by dendritic cells

(2012) M. Kanamori et al.   INTERNATIONAL IMMUNOLOGY

Globosides but Not Isoglobosides Can Impact the Development of Invariant NKT Cells and Their Interaction with Dendritic Cells

(2012) S. Porubsky et al.   JOURNAL OF IMMUNOLOGY

Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model

(2012) Maria Fatima Macedo et al.   MOLECULAR GENETICS AND METABOLISM

Enzyme replacement therapy in patients with Fabry disease: State of the art and review of the literature

(2012) Antonio Pisani et al.   MOLECULAR GENETICS AND METABOLISM

Structural Basis for the Recognition of C20:2-αGalCer by the Invariant Natural Killer T Cell Receptor-like Antibody L363

(2011) Esther Dawen Yu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Recognition of β-linked self glycolipids mediated by natural killer T cell antigen receptors

(2011) Daniel G Pellicci et al.   NATURE IMMUNOLOGY

Lysosomal α-Galactosidase Controls the Generation of Self Lipid Antigens for Natural Killer T Cells

(2010) Alexandre Darmoise et al.   IMMUNITY

Raising the NKT cell family

(2010) Dale I Godfrey et al.   NATURE IMMUNOLOGY

Alpha Anomers of iGb3 and Gb3 Stimulate Cytokine Production by Natural Killer T Cells

(2009) Ning Yin et al.   ACS Chemical Biology

Leukocyte perturbation associated with Fabry disease

(2009) P. Rozenfeld et al.   JOURNAL OF INHERITED METABOLIC DISEASE